However, blocking Wnt receptors with monoclonal antibodies such as vantictumab and ipafricept (a fusion protein consisting of the extracellular ligand-binding domain of FZD8 and the IgG1 Fc fragment) may also be an interesting treatment strategy in myocardial infarction. The gene discussed is FZD8; the disease is myocardial infarction.